All Stories

  1. A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab

    Article • Journal of Neurosurgery, July 2017, Journal of Neurosurgery Publishing Group (JNSPG)

    James Hodge